(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of STK17B mRNA] CTD PMID:31150632 1,1-dichloroethene increases expression ISO RGD:732464 6480464 vinylidene chloride results in increased expression of STK17B mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:732464 6480464 1, 2-Dimethylhydrazine results in decreased expression of STK17B mRNA CTD PMID:22206623 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:732463 6480464 Dihydrotestosterone results in increased expression of STK17B mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732463 6480464 Tetrachlorodibenzodioxin results in increased expression of STK17B mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of STK17B mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732464 6480464 Tetrachlorodibenzodioxin affects the expression of STK17B mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of STK17B mRNA CTD PMID:21215274 , PMID:33387578 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of STK17B mRNA CTD PMID:23537331 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of STK17B mRNA CTD PMID:19643169 2-hydroxypropanoic acid increases expression ISO RGD:732463 6480464 Lactic Acid results in increased expression of STK17B mRNA CTD PMID:30851411 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of STK17B mRNA CTD PMID:19643169 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732463 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STK17B mRNA CTD PMID:28628672 4-hydroxynon-2-enal decreases expression ISO RGD:732464 6480464 4-hydroxy-2-nonenal results in decreased expression of STK17B mRNA CTD PMID:19191707 5-aza-2'-deoxycytidine multiple interactions ISO RGD:732463 6480464 [Decitabine co-treated with Depsipeptides] results in increased expression of STK17B mRNA CTD PMID:17064661 8-Br-cAMP decreases expression ISO RGD:732463 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of STK17B mRNA CTD PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of STK17B mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:732464 6480464 Aflatoxin B1 results in increased expression of STK17B mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:732463 6480464 Aflatoxin B1 results in increased methylation of STK17B intron CTD PMID:30157460 aflatoxin M1 decreases expression ISO RGD:732463 6480464 Aflatoxin M1 results in decreased expression of STK17B mRNA CTD PMID:30928695 all-trans-retinoic acid multiple interactions ISO RGD:732463 6480464 [Tretinoin co-treated with arsenic trioxide] results in decreased expression of STK17B mRNA CTD PMID:15894607 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of STK17B mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:732463 6480464 Antirheumatic Agents results in decreased expression of STK17B mRNA CTD PMID:24449571 arsane affects expression ISO RGD:732463 6480464 Arsenic affects the expression of STK17B mRNA CTD PMID:18414638 arsane affects methylation ISO RGD:732463 6480464 Arsenic affects the methylation of STK17B gene CTD PMID:25304211 arsenic atom affects expression ISO RGD:732463 6480464 Arsenic affects the expression of STK17B mRNA CTD PMID:18414638 arsenic atom affects methylation ISO RGD:732463 6480464 Arsenic affects the methylation of STK17B gene CTD PMID:25304211 arsenous acid multiple interactions ISO RGD:732463 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of STK17B mRNA CTD PMID:15894607 benzo[a]pyrene increases expression ISO RGD:732464 6480464 Benzo(a)pyrene results in increased expression of STK17B mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene decreases methylation ISO RGD:732463 6480464 Benzo(a)pyrene results in decreased methylation of STK17B 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:732463 6480464 7 more ... CTD PMID:20382639 benzo[e]pyrene increases methylation ISO RGD:732463 6480464 benzo(e)pyrene results in increased methylation of STK17B intron CTD PMID:30157460 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of STK17B mRNA CTD PMID:17010207 more ... bisphenol A decreases expression ISO RGD:732464 6480464 bisphenol A results in decreased expression of STK17B mRNA CTD PMID:25594700 bisphenol F multiple interactions ISO RGD:732463 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STK17B mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:732464 6480464 bisphenol F results in increased expression of STK17B mRNA CTD PMID:30951980 butanal increases expression ISO RGD:732463 6480464 butyraldehyde results in increased expression of STK17B mRNA CTD PMID:26079696 caffeine decreases phosphorylation ISO RGD:732463 6480464 Caffeine results in decreased phosphorylation of STK17B protein CTD PMID:35688186 calcitriol increases expression ISO RGD:732463 6480464 Calcitriol results in increased expression of STK17B mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:732463 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of STK17B mRNA CTD PMID:21592394 carbon nanotube decreases expression ISO RGD:732464 6480464 Nanotubes, Carbon results in decreased expression of STK17B mRNA CTD PMID:25554681 chloroprene decreases expression ISO RGD:732464 6480464 Chloroprene results in decreased expression of STK17B mRNA CTD PMID:23125180 ciguatoxin CTX1B affects expression ISO RGD:732464 6480464 Ciguatoxins affects the expression of STK17B mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:732464 6480464 Cisplatin results in increased expression of STK17B mRNA CTD PMID:21489989 cisplatin decreases expression ISO RGD:732463 6480464 Cisplatin results in decreased expression of STK17B mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:732463 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of STK17B mRNA CTD PMID:27392435 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of STK17B mRNA CTD PMID:26033743 copper atom multiple interactions ISO RGD:732463 6480464 [NSC 689534 binds to Copper] which results in increased expression of STK17B mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of STK17B mRNA CTD PMID:26033743 copper(0) multiple interactions ISO RGD:732463 6480464 [NSC 689534 binds to Copper] which results in increased expression of STK17B mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO RGD:732463 6480464 Copper Sulfate results in increased expression of STK17B mRNA CTD PMID:19549813 depsipeptide increases expression ISO RGD:732463 6480464 Depsipeptides results in increased expression of STK17B mRNA CTD PMID:17064661 depsipeptide multiple interactions ISO RGD:732463 6480464 [decitabine co-treated with Depsipeptides] results in increased expression of STK17B mRNA CTD PMID:17064661 dexamethasone increases expression ISO RGD:732463 6480464 Dexamethasone results in increased expression of STK17B mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:732463 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STK17B mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO RGD:732463 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of STK17B mRNA CTD PMID:15894607 diazinon affects expression EXP 6480464 Diazinon affects the expression of STK17B mRNA CTD PMID:22546817 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of STK17B mRNA CTD PMID:22546817 doxorubicin multiple interactions ISO RGD:732464 6480464 Iloprost inhibits the reaction [PTGS2 gene mutant form promotes the reaction [Doxorubicin results in increased expression of STK17B mRNA]], PTGS2 gene mutant form promotes the reaction [Doxorubicin results in increased expression of STK17B mRNA] CTD PMID:16617129 fenamidone increases expression ISO RGD:732464 6480464 fenamidone results in increased expression of STK17B mRNA CTD PMID:27029645 formaldehyde increases expression ISO RGD:732463 6480464 Formaldehyde results in increased expression of STK17B mRNA CTD PMID:20655997 fulvestrant increases methylation ISO RGD:732463 6480464 Fulvestrant results in increased methylation of STK17B gene CTD PMID:31601247 genistein increases expression EXP 6480464 Genistein results in increased expression of STK17B mRNA CTD PMID:17010207 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of STK17B mRNA CTD PMID:22061828 , PMID:33387578 iloprost multiple interactions ISO RGD:732464 6480464 Iloprost inhibits the reaction [PTGS2 gene mutant form promotes the reaction [Doxorubicin results in increased expression of STK17B mRNA]] CTD PMID:16617129 indometacin multiple interactions ISO RGD:732463 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STK17B mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:732464 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of STK17B mRNA CTD PMID:36331819 L-ascorbic acid multiple interactions ISO RGD:732463 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of STK17B mRNA CTD PMID:17639512 leflunomide increases expression ISO RGD:732463 6480464 leflunomide results in increased expression of STK17B mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:732463 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STK17B mRNA CTD PMID:35811015 methapyrilene increases methylation ISO RGD:732463 6480464 Methapyrilene results in increased methylation of STK17B intron CTD PMID:30157460 methylmercury chloride decreases expression ISO RGD:732463 6480464 methylmercuric chloride results in decreased expression of STK17B mRNA CTD PMID:28001369 nickel atom increases expression ISO RGD:732463 6480464 Nickel results in increased expression of STK17B mRNA CTD PMID:24768652 , PMID:25583101 Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of STK17B mRNA CTD PMID:17010207 ozone multiple interactions ISO RGD:732464 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of STK17B mRNA CTD PMID:34911549 p-menthan-3-ol decreases expression ISO RGD:732463 6480464 Menthol results in decreased expression of STK17B mRNA CTD PMID:26760959 paracetamol affects expression ISO RGD:732464 6480464 Acetaminophen affects the expression of STK17B mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of STK17B mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:732463 6480464 Acetaminophen results in increased expression of STK17B mRNA CTD PMID:22230336 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:732464 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of STK17B mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of STK17B mRNA CTD PMID:36331819 pirinixic acid increases expression ISO RGD:732464 6480464 pirinixic acid results in increased expression of STK17B mRNA CTD PMID:18301758 more ... propiconazole increases expression ISO RGD:732464 6480464 propiconazole results in increased expression of STK17B mRNA CTD PMID:21278054 quercetin multiple interactions ISO RGD:732463 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of STK17B mRNA CTD PMID:17639512 rac-lactic acid increases expression ISO RGD:732463 6480464 Lactic Acid results in increased expression of STK17B mRNA CTD PMID:30851411 resorcinol decreases expression ISO RGD:732463 6480464 resorcinol results in decreased expression of STK17B mRNA CTD PMID:22623647 resveratrol decreases expression ISO RGD:732463 6480464 resveratrol results in decreased expression of STK17B mRNA CTD PMID:15767336 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:732463 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STK17B mRNA CTD PMID:35811015 silver atom decreases expression ISO RGD:732464 6480464 Silver results in decreased expression of STK17B mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:732464 6480464 Silver results in decreased expression of STK17B mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:732464 6480464 sodium arsenite results in increased expression of STK17B mRNA CTD PMID:36209798 sulindac sulfide increases expression ISO RGD:732463 6480464 sulindac sulfide results in increased expression of STK17B mRNA CTD PMID:16184548 sunitinib decreases expression ISO RGD:732463 6480464 Sunitinib results in decreased expression of STK17B mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:732464 6480464 Tamoxifen affects the expression of STK17B mRNA CTD PMID:20937368 testosterone affects expression ISO RGD:732463 6480464 Testosterone affects the expression of STK17B mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:732463 6480464 Testosterone results in increased expression of STK17B mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:732463 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of STK17B mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of STK17B mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:732464 6480464 Carbon Tetrachloride results in increased expression of STK17B mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of STK17B mRNA] CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of STK17B mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression ISO RGD:732464 6480464 titanium dioxide results in increased expression of STK17B mRNA CTD PMID:23557971 Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of STK17B mRNA CTD PMID:17553608 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of STK17B mRNA CTD PMID:33387578 trichostatin A affects expression ISO RGD:732463 6480464 trichostatin A affects the expression of STK17B mRNA CTD PMID:28542535 troglitazone increases expression ISO RGD:732464 6480464 troglitazone results in increased expression of STK17B mRNA CTD PMID:28973697 tunicamycin increases expression ISO RGD:732464 6480464 Tunicamycin results in increased expression of STK17B mRNA CTD PMID:17127020 urethane increases expression ISO RGD:732463 6480464 Urethane results in increased expression of STK17B mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:732463 6480464 Valproic Acid results in increased expression of STK17B mRNA CTD PMID:24935251 vancomycin decreases expression ISO RGD:732464 6480464 Vancomycin results in decreased expression of STK17B mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of STK17B mRNA CTD PMID:19015723 vorinostat increases expression ISO RGD:732463 6480464 vorinostat results in increased expression of STK17B mRNA CTD PMID:27188386